Oleander Medical Technologies
Baton Rouge
About Oleander Medical Technologies
Oleander Medical Technologies is developing a revolutionary new treatment to destroy many of the most invasive and deadly cancers using a process called Targeted Osmotic Lysis (TOL).Unlike radiation or chemotherapy, TOL has the potential to destroy cancer without ravaging the rest of the body, to eliminate the disease in a matter of minutes, without pain and with minimal discomfort, and at a much lower cost than current treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.1M
- Last round: Undisclosed (Jul 2024)
- Website: oleandermedicaltechnologies.com
- Phone: (225) 413-7658
Industries & Categories
Biotechnology, Clinical Trials, Communities, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/oleander-medical-technologies-143352 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.